Health
Waisman Biomanufacturing partners with Heat Biologics to manufacture COVID-19 vaccine – Mirage News
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering…
Waisman Biomanufacturing staff operate a centrifuge that allows for cell separation. The UW-Madison biopharmaceutical contract manufacturer is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Todd Brown, Media Solutions, UW School of Medicine and Public Health
Waisman Biomanufacturing at the University of Wisconsin-Madison is partnering with Heat Biologics to produce a COVID-19 vaccine for phase 1 and phase 2 clinical trials. Phase 1 trials c…
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News22 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal
-
Noosa News14 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News23 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo